AMTX-100 CF

· Amytrx Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AMTX-100 CF, covering 2025-05-02 to 2025-05-02. Get the full timeline:

Most recent: Clinical Trial Update: Topically Applied AMTX-100 CF for Adult Patients With Mild to Moderate Atopic Dermatitis [Phase 1, Phase 2]